Search results for:
empagliflozin-metFORMIN
empagliflozin-metFORMIN
Drug Name |
Form |
Strength |
Formulary Unrestricted |
Formulary Restricted |
Non-Formulary |
Interchange |
Synjardy XR |
TABLET, EXTENDED RELEASE, ORAL |
5 mg-1,000 mg, 10 mg-1,000 mg, 12.5 mg-1,000 mg, 25 mg-1,000 mg, |
|
|
|
|
Synjardy |
TABLET, ORAL |
5 mg-500 mg, 5 mg-1,000 mg, 12.5 mg-500 mg, 12.5 mg-1,000 mg |
|
|
|
|
Last updated: Aug. 9, 2023
Synjardy is approved for sample use in HH Endocrinology and Diabetes Clinics.
ORDERED FORMULATION
THERAPEUTIC INTERCHANGE
empagliflozin-metFORMIN (Synjardy)
empagliflozin (Jardiance) AND metFORMIN (Fortamet, Glumetza)
empagliflozin-metFORMIN (Synjardy XR)**
empagliflozin (Jardiance) AND metFORMIN (Fortamet, Glumetza)
**CAUTION: empagliflozin-metFORMIN (Synjardy XR) recommended dosing for the 5 mg-1000 mg XR and 12.5 mg-1000 mg XR tablets is for TWO tablets once daily, while recommended dosing for the 10 mg-1,000 mg XR and 25 mg-1,000 mg XR tablets is for ONE tablet once daily. Please be extra cautious when interchanging this medication to confirm that the interchange is appropriate (total daily dose of empagliflozin should be 10 mg or 25 mg).
Synjardy medication guide
Synjardy XR medication guide
metFORMIN -- hold for 48 hours post IV contrast media per radiologist, contraindications with CHF, renal disease, hepatic disease, and age. Pharmacist may order SCr.
Synjardy -- empagliflozin/metFORMIN combination in 4 strengths, dosed bid. Interchange to separate drugs each in same daily dose utilizing empagliflozin once daily and metFORMIN ER once daily.
Reviewed: 17 Nov 2015 (Synjardy)